For Quick Alerts
For Daily Alerts

Sun Pharma Is The Top Gainer On Nifty; Stock Rallies Over 7% After Q4FY18 Results


Stock of pharma major Sun Pharma rallied in trade by over 7% to hit an intra-day high of Rs. 504.95 on the NSE. The stock's performance is driven by good set of fourth quarterly numbers for the FY 2017-18 which reported a net profit to the tune of Rs. 1300 crore due to one-time tax gain of as much as Rs. 259 crore.

Sun Pharma Is The Top Gainer On Nifty; Stock Rallies Over 7%

Singhvi, MD of the company said, "Our Q4 performance is in-line with our guidance. Over the last four quarters, we have been able to record a gradual improvement in performance despite a challenging US generic pricing environment.

"FY19 will mark the crossing of some important milestones in our specialty journey with the likely launch of 3 specialty products in the US - Ilumya, OTX-101 and Yonsa - which will entail upfront investments. We are also planning to conduct additional clinical trials for a new indication of Ilumya. We will continue to evaluate opportunities in the specialty segment to further enhance this business', added Sanghvi.

In a press release, the pharma company said the decline in revenue from operation amounting to as much as 2% is primarily on account of the company's US and the API businesses. Rest all of the businesses have been doing well for the quarter.

Meanwhile the stock of Sun Pharma is the most actively traded stock and also the top gainer at the same time on the Nifty.

The stock while reporting was quoting higher by 7.60% at Rs 501.9 on the NSE against previous day's closing price of Rs. 466.45.

Read more about: sun pharma q4fy18 results
Story first published: Monday, May 28, 2018, 11:35 [IST]
Company Search
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more